These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 17368011

  • 1. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM.
    Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
    [Abstract] [Full Text] [Related]

  • 2. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 3. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 10; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 4. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr 10; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug 10; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 6. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS, Wang L, To T, Luo J, Upshur RE.
    COPD; 2008 Aug 10; 5(4):229-34. PubMed ID: 18671148
    [Abstract] [Full Text] [Related]

  • 7. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.
    Perng DW, Wu CC, Su KC, Lee YC, Perng RP, Tao CW.
    Respirology; 2006 Sep 10; 11(5):598-602. PubMed ID: 16916333
    [Abstract] [Full Text] [Related]

  • 8. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA, Donohue JF.
    Semin Respir Crit Care Med; 2010 Jun 10; 31(3):321-33. PubMed ID: 20496301
    [Abstract] [Full Text] [Related]

  • 9. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
    COPD; 2007 Jun 10; 4(2):127-34. PubMed ID: 17530506
    [Abstract] [Full Text] [Related]

  • 10. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs.
    Drescher GS, Carnathan BJ, Imus S, Colice GL.
    Respir Care; 2008 Dec 10; 53(12):1678-84. PubMed ID: 19025702
    [Abstract] [Full Text] [Related]

  • 11. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
    Kiri VA, Bettoncelli G, Testi R, Viegi G.
    Respir Med; 2005 Sep 10; 99(9):1115-24. PubMed ID: 15921904
    [Abstract] [Full Text] [Related]

  • 12. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA, Fabbri LM, Davis KJ, Soriano JB.
    Respir Med; 2009 Jan 10; 103(1):85-90. PubMed ID: 18793832
    [Abstract] [Full Text] [Related]

  • 13. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease.
    Cramer JA, Bradley-Kennedy C, Scalera A.
    Can Respir J; 2007 Jan 10; 14(1):25-9. PubMed ID: 17315055
    [Abstract] [Full Text] [Related]

  • 14. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
    Mapel DW, Hurley JS, Roblin D, Roberts M, Davis KJ, Schreiner R, Frost FJ.
    Respir Med; 2006 Apr 10; 100(4):595-609. PubMed ID: 16199151
    [Abstract] [Full Text] [Related]

  • 15. Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD.
    Andò F, Ruggeri P, Girbino G, Cazzola M.
    Respir Med; 2008 Jun 10; 102(6):815-8. PubMed ID: 18343646
    [Abstract] [Full Text] [Related]

  • 16. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T, Lapidus R, Maleki-Yazdi R, Timmer W, Rubin E, Lowe L, Bateman E.
    Respir Med; 2008 Jan 10; 102(1):32-41. PubMed ID: 17996436
    [Abstract] [Full Text] [Related]

  • 17. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
    Gagnon YM, Levy AR, Spencer MD, Hurley JS, Frost FJ, Mapel DW, Briggs AH.
    Respir Med; 2005 Dec 10; 99(12):1534-45. PubMed ID: 16291076
    [Abstract] [Full Text] [Related]

  • 18. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC, Lau H, La HO, Choi IS, Geba GP.
    Curr Med Res Opin; 2010 Feb 10; 26(2):297-306. PubMed ID: 19961283
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of tiotropium in the prevention of exacerbations of COPD.
    Anzueto A, Miravitlles M.
    Ther Adv Respir Dis; 2009 Jun 10; 3(3):103-11. PubMed ID: 19617284
    [Abstract] [Full Text] [Related]

  • 20. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.
    Koumis T, Samuel S.
    Clin Ther; 2005 Apr 10; 27(4):377-92. PubMed ID: 15922812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.